The True Utility of Predictive Models Based on Magnetic Resonance Imaging in Selecting Candidates for Prostate Biopsy
Resumen: Early detection of clinically significant prostate cancer (csPCa) has improved since the introduction of magnetic resonance imaging (MRI) and guided biopsies for this purpose; however, suspicion of PCa is still based on elevated serum prostate-specific antigen and/or abnormal digital rectal examination. At present, the decision to perform a prostate biopsy primarily depends on the Prostate Imaging-Reporting and Data System (PI-RADS) score for lesions observed on MRI. Prostate biopsy is typically avoided when negative MRI (PI-RADS <3) is reported owing to its high negative predictive value; nevertheless, uncertain scenarios remain...
Idioma: Inglés
DOI: 10.1016/j.euros.2022.06.002
Año: 2022
Publicado en: European urology open science 42 (2022), 40-41
ISSN: 2666-1691

Factor impacto JCR: 2.5 (2022)
Categ. JCR: UROLOGY & NEPHROLOGY rank: 51 / 88 = 0.58 (2022) - Q3 - T2
Factor impacto CITESCORE: 1.7 - Medicine (Q3)

Factor impacto SCIMAGO: 0.576 - Urology (Q2)

Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI20/01666
Tipo y forma: (Published version)
Área (Departamento): Área Urología (Dpto. Cirugía)
Exportado de SIDERAL (2024-03-18-16:51:35)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
articulos > articulos-por-area > urologia



 Notice créée le 2022-10-27, modifiée le 2024-03-19


Versión publicada:
 PDF
Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)